US regulators are 'very concerned' about the side effects of AstraZeneca's vaccine

US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

CONCLUSION: Vaccine-related anaphylaxis seems to have been very rare in the past, but health care professionals must always be aware of anaphylaxis. PMID: 32989932 [PubMed - in process]
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
Conclusions: A recommendation by a health care provider may be not enough to motivate Latina immigrant mothers to vaccinate their daughters. Further efforts should focus on increasing awareness regarding HPV and cervical cancer, heightening perceived risk of HPV infection among daughters and boosting self-efficacy to get their children vaccinated against HPV. PMID: 32989366 [PubMed - in process]
Source: Ethnicity and Disease - Category: International Medicine & Public Health Tags: Ethn Dis Source Type: research
Trial shows‘robust’ immune response; warning overglobal impact of travel collapse;Belgium death toll exceeds 10,000World Bank announces $12bn plan for vaccines for poor countries‘Only time will tell’: Russia places huge bet on Covid vaccineGermans embrace fresh air to tackle coronavirusIsrael bans mass protests as Covid lockdown tightensUK coronavirus updates – live3.48pmBSTKenya ’s auditor general says the country stands to lose $21 million in the procurement of COVID-19 medical supplies because the Kenya Medical Supplies Agency failed to follow procurement law.General Nancy Gathangu on...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news UK news Science Infectious diseases US news Australia news Microbiology Medical research Source Type: news
Oct 13, 2020. . Sponsored by Resources for Integrated Care
Source: Rural events via the Rural Assistance Center - Category: Rural Health Source Type: events
This study aimed to analyze the epidemiological profile and factors associated with SARI-related hospitalization and deaths reported in Goi ás. Retrospective cohort study, with data from the investigation files of the Notifiable Diseases Information System ’ s Influenza Web. Multivariate analysis methods were employed to verify the association between exposure variables with the outcomes of ICU admission and death. A total of 4,832 SARI cases were reported in Goi ás from 2013 to 2018. The primary etiological diagnosis was Influenza A (22.3%) with the predominant subtype A (H1N1pdm09), followed by the Re...
Source: Ciencia e Saude Coletiva - Category: Occupational Health Source Type: research
Campaign scoring countries for global access efforts calls for more British transparencyCoronavirus – latest updatesSee all our coronavirus coverageThe UK is doing more than most countries to support access to Covid vaccines for the poorest populations in the world, but it is not transparent enough about the deals it is doing at home, according to an international aid organisation launching a tracker.The One campaign has given countries and pharmaceutical companies scores for the efforts they have made to ensure the poorest get vaccines. In the vaccine access test no country or company scores green, the top rating, c...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Health policy Politics Society UK news Medical research Infectious diseases Public services policy Science World news Pharmaceuticals industry AstraZeneca Business Microbiology Global development Vaccines Source Type: news
Oct 2, 2020. . Sponsored by National Academies of Sciences, Engineering, and Medicine
Source: Rural events via the Rural Assistance Center - Category: Rural Health Source Type: events
Authors: Lotfinejad P, Asadzadeh Z, Najjary S, Somi MH, Hajiasgharzadeh K, Mokhtarzadeh A, Derakhshani A, Roshani E, Baradaran B Abstract The outbreak of coronavirus disease 2019 (COVID-19) has posed a serious threat to public health. There is an urgent need for discovery methods for the prevention and treatment of COVID-19 infection. Understanding immunogenicity together with immune responses are expected to provide further information about this virus. We hope that this narrative review article may create new insights for researchers to take great strides toward designing vaccines and novel therapies in the near ...
Source: Immunological Investigations - Category: Allergy & Immunology Tags: Immunol Invest Source Type: research
Conditions:   Influenza;   Influenza -Like Illness Intervention:   Biological: Influenza vaccination at different time points Sponsors:   University of Leicester;   Sanofi Pasteur, a Sanofi Company;   World Health Organization;   University of Warwick;   University Hospitals, Leicester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
While childhood vaccine administration and vaccination coverage rates fell in the US in the early months of the COVID-19 pandemic, the latest data shows they improved in May and June.Morbidity &Mortality Weekly Report
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
More News: AstraZeneca | Health | Vaccines